

Scores at time of recommendation (January 4, 2026)
2021
Weather-related catastrophe losses totaled approximately $962.1M, creating a net negative impact on results. Despite this, the company reported net income of roughly $731.5M for the year. The market viewed this as evidence of catastrophe volatility inherent to the franchise, while recognizing that profitability persisted through the cycle. Stock price action remained volatile, with sensitivity to loss announcements driving drawdown risk. [28], [30]
Q3 2022
The company reported a net loss attributable to common shareholders of $825.3M and an operating loss of $396.7M. Market sentiment shifted as catastrophe losses and reserve pressure moved investor focus from steady compounding to capital and underwriting risk management. An extended drawdown followed through the remainder of the year. [27], [28]
2022 (full year)
Full-year net loss to common shareholders reached approximately $1.096B, with total investment results contributing a loss of roughly $1.2B and a combined ratio near 97.7%. This stress year—driven by large catastrophe hits and investment volatility—prompted management to signal a need for pricing discipline and balance-sheet strengthening. Stock price reached a trough relative to prior cycles. [28], [29], [30], [31]
January 2023 renewal season
Management implemented a "reset on rates" into the 1/1/2023 renewals to rebuild the margin of safety following elevated catastrophe losses. Market perception began shifting toward a pricing hardening cycle and a path back to attractive underwriting returns. Early signs of bottoming emerged as recovery began. [31]
May 22, 2023 — Validus acquisition announced
The company entered a definitive agreement to acquire AIG's Validus Re, including AlphaCat and Talbot treaty renewal rights, for $2.985B (approximately $2.735B in cash plus $250M in RenRe shares). The market viewed this as a strategic move to build scale and diversification through treaty reinsurance and ILS capability, while pricing in near-term financing and integration dilution. The transaction acted as a catalyst for accumulation and positive re-rating. [15], [14], [21], [22]
November 1, 2023 — Validus acquisition closed
The acquisition completed with AIG receiving cash and RenRe shares. Rating agencies took related actions around the close. Market focus shifted to integration execution, reserve arrangements, and synergy realization, with recognition of an enlarged property-catastrophe footprint. Initial post-close uplift was followed by consolidation as integration proceeded. [13], [18], [24], [34]
Q4 2023 / December 2023 — Bermuda tax enactment and deferred tax asset
Bermuda enacted a 15% corporate income tax effective January 1, 2025. RenRe recorded a net deferred tax asset of approximately $593.8M in Q4 2023, materially boosting book and tangible book value. The company reported strong Q4 and full-year operating income. This one-time book boost, combined with a "step-change" in property-catastrophe pricing, reframed the narrative from recovery to a high-return underwriting story. The stock rallied on improved fundamentals and enhanced book metrics. [37], [38], [4], [33]
January 1, 2024 renewals and 2024 outlook
At the 1/1/2024 renewals, RenRe retained legacy lines and expanded its share in property catastrophe and specialty without conceding pricing or terms. Validus integration continued to affect expense ratios. The market reinforced its view of pricing power and sustainable underwriting margins, treating the company as returning to durable high returns despite integration drag. The stock sustained an uptrend with episodic volatility tied to catastrophe news. [4], [3], [34]
H1–H2 2024 — continued underwriting strength and integration costs
Quarterly reports through 2024 reiterated strong operating returns with high annualized operating ROE in several quarters, while transaction, integration, and compensation expenses remained elevated. The market increasingly positioned RenRe as an underwriting compounder with temporary expense headwinds from Validus integration. Uptrend continued with pullbacks on event noise. [5], [3], [12], [34]
2025 — Bermuda tax effective; record operating performance; capital returns
Bermuda's 15% corporate tax became effective on January 1, 2025. RenRe delivered materially stronger full-year results (reported in early 2026) and executed large share repurchases and shareholder distributions. Despite higher statutory tax, the market rewarded sustained underwriting performance and disciplined capital allocation. Buybacks and dividends reinforced a value-return narrative. Mature uptrend continued with multiple positive re-ratings around earnings and capital-return announcements. [37], [40], [6], [11], [10], [8]
Q1–Q2 2025
Q1 2025 showed divergence between GAAP and operating metrics: reported net income available to common shareholders was $161.1M while operating loss attributable to common shareholders was $69.8M. Q2 2025 beat estimates with $376M in share repurchases. Short-term volatility emerged as GAAP results and one-offs created noise, but momentum remained driven by underlying underwriting and capital returns. Short pullbacks were followed by resumed uptrend. [1], [10], [11]
Full-year 2025 reported in early 2026
Full-year 2025 results showed record operating income and strong returns on equity, with tangible book value growth and heavy capital deployment through repurchases. This confirmed conversion to multi-year underwriting outperformance plus shareholder-friendly capital policy, with the market treating RenRe as a top-tier reinsurance franchise. Strong rally and valuation re-rating followed versus earlier cycle troughs. [6], [11]
Mid-2026 (as of July 11, 2026)
The stock is trading at $314.99. Q1 2026 and ongoing disclosures remain on the company investor site as the business operates post-Validus with continued underwriting focus and active capital management. Investors assign a premium for sustained underwriting returns, scale from Validus, and aggressive capital returns, while acknowledging cyclical exposure to large catastrophe years and market or investment volatility. The stock is in a mature uptrend and momentum phase; principal risk remains a sizable catastrophe or investment-market shock that would trigger a swift drawdown. [2], [6], [11]
RenaissanceRe is a leading catastrophe reinsurer with exceptional operational discipline and structural competitive advantages. The company benefits from a business model in which customers are forced by regulation to reinsure and inflation and rising claims sums tend to lead to higher premiums. The strong capital base, coupled with intelligent capital allocation and an attractive valuation level, make the share an unusually solid player in an often volatile sector.
RenaissanceRe is a Bermuda-based global reinsurer with a focused mandate in property-catastrophe and specialty reinsurance. It competes against a diverse set: global reinsurers like Munich Re, Swiss Re, and Hannover Re; Bermuda-based specialists including Everest, Axis, and Arch; and hybrid players like Markel and Berkshire Hathaway that operate meaningful reinsurance franchises alongside insurance. The business carries three material risk dimensions. Catastrophe-loss volatility remains the structural anchor—large single events can swing results meaningfully. The reinsurance cycle itself creates pricing pressure, particularly as alternative capital and ILS competitors continue to absorb share in soft markets. Investment returns matter more than most realize; capital levels and credit ratings feed directly into underwriting capacity and client appetite, creating a feedback loop that compounds during stressed periods.
RenaissanceRe competes in a reinsurance market shaped by established multiline giants, specialized Bermudian operators, and a rising tide of alternative capital and ILS managers. The resulting dynamic—more capacity chasing the same risks—has compressed pricing and left the company navigating two overlapping vulnerabilities: the inherent volatility of property-catastrophe and specialty underwriting, and the quieter sensitivities embedded in investment returns and reserve adequacy [Umbrex; CB Insights; MarketBeat].
| Company | Ticker |
|---|---|
| Swiss Re | SREN.SIX |
| Arch Capital Group | ACGL.NASDAQ |
| AXIS Capital | AXS.NYSE |
| Everest Group (formerly Everest Re) | EG.NYSE |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free Trial| Period | Renaissancere Holdings Ltd | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | +2.37% | +2.35% | +1.51% |
| 3M | -2.24% | -3.10% | -8.80% |
| 6M | +14.32% | +15.83% | +4.61% |
| 1Y | +29.40% | +25.63% | +7.14% |
| 3Y | +59.09% | +4.03% | -14.70% |
| 5Y | +109.95% | +49.62% | +22.71% |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHow the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 4.7 | 1.1 | 1.1 | 3.1 |
| 1Y ago | 5.7 | 0.9 | 1.0 | 2.9 |
| 3Y ago | 21.4 | 1.2 | 1.2 | 4.5 |
| 5Y ago | 16.9 | 1.4 | 1.0 | 5.0 |
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
| Year | Dividend | Yield at payment | Avg. yield |
|---|---|---|---|
| 2026 | 0.41 USD | 0.14% | 0.17% |
| 2026 | 0.41 USD | 0.14% | |
| 2025 | 0.40 USD | 0.15% | |
| 2025 | 0.40 USD | 0.16% | |
| 2025 | 0.40 USD | 0.16% | |
| 2025 | 0.40 USD | 0.17% | |
| 2024 | 0.39 USD | 0.15% | |
| 2024 | 0.39 USD | 0.15% | |
| 2024 | 0.39 USD | 0.18% | |
| 2024 | 0.39 USD | 0.16% | |
| 2023 | 0.38 USD | 0.19% | |
| 2023 | 0.38 USD | 0.19% | |
| 2023 | 0.38 USD | 0.20% | |
| 2023 | 0.38 USD | 0.20% | |
| 2022 | 0.37 USD | 0.20% |
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 12.75B | 11.65B | 9.09B | 5.05B | 5.27B |
| Operating income (EBIT) | 4.13B | 3.09B | 3.20B | -1.17B | -66.57M |
| Net income | 2.68B | 1.87B | 2.56B | -1.06B | -40.16M |
| Free cash flow | 3.69B | 4.16B | 1.91B | 1.12B | 1.23B |
| Total assets | 53.80B | 50.71B | 49.01B | 36.55B | 33.96B |
| Equity | 11.61B | 10.57B | 9.45B | 9.86B | 10.18B |
| Net debt | 598.02M | 210.09M | 81.14M | -23.90M | -690.67M |